Introduction
Activating mutations of the ras gene family and constitutive activation of pp60 c-src , the product of the src proto-oncogene, are among the genetic and epigenetic alterations most frequently observed in human colorectal cancer. In order to get human colonic cells in which these frequent alterations are reproduced, we have developed and maintained in culture Caco-2 cell lines transfected either with an activated human Val 12 Ha-ras gene or with the cDNA encoding the PyMT antigen, a membrane protein that associates with pp60 c-src and constitutively increases its activity (Cantley et al., 1991) . These Ha-ras and PyMT-transfected cells provide suitable models to examine the molecular mechanisms involved in the deregulation of the proliferation of colon cancer cells. Using these models, we recently reported that the constitutive increase in the proliferation of Caco-2 cells induced by oncogenic p21 ras and PyMT/pp60 c-src was associated with constitutive activation of PKC together with overexpression of PKCa (Delage et al., 1993) , the major conventional PKC isotype expressed in this cell type (Bissonnette et al., 1994) . These alterations were responsible for a decreased mitogenic response of oncogene-transfected Caco-2 cells to insulin (BaronDelage et al., 1994) .
The insulin-like growth factor IGF-II is a polypeptide which exerts its powerful mitogenic activity through the type 1 IGFR (IGF1R) (Humbel, 1990) . Changes in IGF-II and IGF1R expression were shown to play a role in the neoplastic transformation of various cell types (Christofori et al., 1994; Baserga, 1995; Torestky and Helman, 1996) . Overexpression of IGF-II has been found in 30 ± 40% of colorectal tumors (Tricoli et al., 1986; Lambert et al., 1990) , indicating that autrocrine production of IGF-II may also play a role in the deregulation of the proliferation of colon cancer cells. IGF-II is the major IGF secreted by Caco-2 cells (Hoe¯ich et al., 1994; Zarrilli et al., 1994; Park et al., 1996) and evidence was provided that an autocrine IGF-II/IGF1R loop is involved in the control of the proliferation of this cell line (Lahm et al., 1994; Zarrilli et al., 1994 Zarrilli et al., , 1996 .
The human IGF-II gene is a complex transcription unit which is regulated by activation of multiple promoters (P1 to P4). Transcription of this gene yields multiple mRNA species which are expressed in a tissue-speci®c manner (Holthuizen et al., 1990) . In Caco-2 cells, IGF-II mRNA consists of two major transcripts of 6.0 and 4.8 kb (Zarrilli et al., 1994) . These transcripts are respectively derived from the IGF-II gene P3 and P4 promoters, both of which contain several sites speci®c for the Sp1 transcription factor (Holthuizen et al., 1993) . Sp1 is a member of the C 2 -H 2 zinc ®nger protein family which is ubiquitously expressed. It interacts with GC boxes and its involved in the regulation of various genes (Obeid et al., 1992; D'Angelo et al., 1996; Ye et al., 1996) . Although the activity of Sp1 is generally believed to be constitutive, there is some evidence that it can be regulated by dierent mechanisms (Leggett et al., 1995; Han and Kudlow, 1997) and/or agonists (Rohl et al., 1997; Armstrong et al., 1997) including PMA, a well known PKC activator (Biggs et al., 1996; D'Angelo et al., 1996) .
In the present study, we ®rst examined the IGF system, that is expression and/or secretion of IGFs, type 1 and type 2 IGFRs and IGF-binding proteins (IGFBPs) in control and ras-and PyMT-transfected Caco-2 cells. We found a marked increase in autocrine IGF-II production in oncogene-transfected cells which was fully responsible for their constitutively increased proliferation. This ®nding prompted us to examine whether the overexpression and activation of PKC previously shown in these cells (Delage et al., 1993) played a role in the oncogene-induced up-regulation of the autocrine IGF-II/IGF1R loop, and if so, to analyse the mechanism(s) involved. Our results show that PKC mediated the transcriptional activation of the IGF-II gene produced by oncogenic p21 ras and PyMT/pp60 c-src in transfected Caco-2 cells. PKC activated the IGF-II gene by stimulating the activity of the P3 and P4 promoters probably through activation of the Sp1 transcription factor. These results provide the ®rst evidence that ras-and PyMT/src oncogenes up-regulate human colonic cell proliferation through a PKCmediated pathway which stimulates IGF-II gene transcription and thereby increases autocrine IGF-II production. The mechanisms underlying IGF-II gene activation by PKC most probably involve action on Sp1.
Results
Increased IGF-II expression and secretion in oncogenetransfected Caco-2-MT and Caco-2-T cells
In the ®rst set of experiments, we examined the level of IGF-I and IGF-II mRNAs in control Caco-2-H cells and oncogene-transfected Caco-2-MT and Caco-2-T cells. Northern blot analyses indicated that none of these cell lines expressed IGF-I mRNA at a detectable level. A similar observation was previously reported for parental Caco-2 cells (Zarrilli et al., 1994) . In contrast, Caco-2-H cells expressed two major speci®c IGF-II transcripts of 6.0 and 4.8 kb (Figure 1a ) which are derived from the P3 and P4 promoters of the human IGF-II gene respectively (Sussenbach et al., 1991) . In accordance with the study of Zarrilli et al. (1994) , we observed that the transcript of 6.0 kb was more abundant than that of 4.8 kb. In oncogene-transfected Caco-2-MT and Caco-2-T cells, the level of the 6.0 kb IGF-II transcript was increased by about 3 ± 4-fold, as evaluated by densitometric scanning of the autoradiographs and normalizing the results to the 28 S signal ( Figure 1a) . Next, the level of IGF-I and IGF-II proteins secreted into the medium by Caco-2-H, Caco-2-MT and Caco-2-T cells was determined by radioimmunoassay. The three cell lines were switched into serum-free medium (SFM) for these assays. After 48 h, conditioned media were harvested and cleared of IGFBPs by two consecutive extractions before analysis for IGF protein content. In agreement with our previous results (Baron -Delage et al., 1994) , we found that control and oncogene-transfected Caco-2 cells secreted very low and closely similar amounts of IGF-I protein (55 ± Figure 1 IGF-II expression and secretion and IGFBP pro®le in control and oncogene-transfected Caco-2 cells. (a) Total RNA (15 mg) prepared from control Caco-2-H and oncogene-transfected Caco-2-MT and Caco-2-T cells was subjected to Northern blot analysis and hybridized to a 32 P-labelled cDNA probe speci®c for human IGF-II. Filters were subsequently hybridized to a 32 Plabelled 28 S oligonucleotide probe as a control of RNA loading. The relative amounts of the 6.0 kb transcript were quanti®ed by calculating the ratio of IGF-II densitometry to 28 S densitometry and expressed in arbitrary units (AU). Results are the means+s.e.m. from three experiments. (b) After a 48 h serum deprivation, CM were collected, concentrated and assayed for IGF-II content by radioimmunoassay. Results are the means+s.e.m. from three experiments. (c) CM were analysed by ligand blotting using a mixture of 125 I-IGF-I and -II as the probe. The autoradiograph is representative of two experiments
Oncogene stimulation of IGF-II expression through a PKC pathway A Cadoret et al 75 pg/ml). In contrast, Caco-2-H cells produced a fairly detectable amount of IGF-II ( Figure 1b ). As could be expected from the results of Northern blot analyses, the level of IGF-II protein secreted into the medium by oncogene-transfected Caco-2-MT and Caco-2-T cells was increased by abount 3 ± 4-fold ( Figure 1b) . Along with increased IGF-II content, the medium conditioned by oncogene-transfected Caco-2-MT and Caco-2-T cells exhibited a modi®ed IGFBP pro®le, with IGFBP-2 and IGFBP-4 being respectively decreased and increased as compared with the pro®le observed in the medium conditioned by control Caco-2-H cells (Figure 1c ).
Equivalent expression of IGF1R and IGF2R in control and oncogene-transfected Caco-2 cells
To further de®ne the eect of oncogenic p21 ras and PyMT/pp60 c-src on the IGF system, we examined the expression of IGF1R and IGF2R in control and oncogene-transfected Caco-2 cells at the mRNA and/ or protein levels. As shown in Figure 2a , Caco-2-H cells expressed a 11 kb IGF1R transcript, which agrees with results reported by others for parental Caco-2 cells (Hoe¯ich et al., 1994) . The level of this transcript was not modi®ed in oncogene-transfected cells (Figure 2a,d) . Accordingly, the number of IGF1Rs expressed at the surface of these cells was similar with that expressed by the controls, as indicated by the closely similar values of the mean¯uorescence intensity (FI) measured by¯ow cytometry analysis in the three cell lines (Figure 2b ). Figure 2c shows that Caco-2-H, Caco-2-MT and Caco-2-T cells expressed a IGF2R transcript of 9 kb, in agreement with the molecular weight previously found in Caco-2 cells (Hoe¯ich et al., 1994) . The level of this transcript was similar in all three cell lines, as evaluated by densitometric scanning of the autoradiographs (Figure 2d ). Together, our results indicate that oncogenic p21 ras and PyMT/pp60 c-src up-regulate IGF-II expression and secretion in Caco-2 cells without modifying IGF1R and IGF2R levels.
Increased autocrine IGF-II production mediates oncogene stimulation of Caco-2-MT and Caco-2-T cell proliferation
We next examined whether the increased autocrine IGF-II production by oncogene-transfected Caco-2-MT and Caco-2-T cells was responsible for the constitutive increase in their proliferation that we reported in our previous paper (Baron -Delage et al., 1994) . To this end, we measured the proliferation of Caco-2-H, Caco-2-MT and Caco-2-T cells in the presence or absence of either a monoclonal antihuman IGF-II antibody or aIR3, a speci®c IGF1R blocking antibody (Kull et al., 1983) , or control IgG. In these experiments, Caco-2-H, Caco-2-MT and Caco-2-T cells (5610 4 cells/well) were grown for 1 day in the presence of 15% fetal calf serum (FCS) and then switched to SFM. After 48 h, cells were maintained for an additional 24 h in SFM with or without anti-human IGF-II (5 mg/ml) or aIR3 (10 mg/ml) antibodies or isotypic IgG (10 mg/ml) and were then examined for cell number, as evaluated by a colorimetric assay using a tetrazoloium salt (MTT). In accordance with our previous results (Baron-Delage et al., 1994), we observed that, in the absence of the antibodies, the number of Caco-2-MT and Caco-2-T cells was about twofold that of Caco-2-H cells, although the three cell lines had been plated at the same density (Figure 3a) . In contrast, in the presence of the anti-IGF-II or aIR3 antibodies but not of isotypic IgG, the number of Caco-2-MT and Caco-2-T cells was closely similar to that of Caco-2-H cells indicating that both antibodies were much more ecient in inhibiting the proliferation of the oncogene-transfected cells (54% inhibition) than the proliferation of control Caco-2-H cells (28% inhibition). This ®nding shows that an IGF-II autocrine loop is involved in the control of Caco-2 cell proliferation, in accordance with the results reported for parental Caco-2 cells (Lahm et al., 1994; Zarrilli et al., 1994) . More important, this ®nding indicates that increased autocrine IGF-II production in Caco-2-MT and Caco-2T cells mediates the stimulation of their proliferation and therefore suggests increased endogenous activation of the IGF1Rs in these cell lines. To examine this point, IGF1R autophosphorylation was assessed in the three cell lines after immunoprecipitation with the aIR3 antibody and immunoblotting with the PY20 anti-phosphotyrosine antibody. As shown in Figure 3b , IGF1Rs from oncogene-transfected Caco-2-MT and Caco-2-T cells exhibited a 1.8-fold increase in the phosphotyrosine content of their b-subunit relative to IGF1Rs from Caco-2-H cells, pointing to enhanced tyrosine kinase activity of IGF1R b-subunit in oncogene-transfected Caco-2 cells.
As a corollary of the above ®nding, we observed that exogenously added IGFs (10 78 M) had no appreciable eect on the proliferation of Caco-2-MT and Caco-2-T cells whereas they increased the proliferation of Caco-2-H cells by about twofold (Figure 3c ). Similarly, FCS (15%) was far less efficient in Caco-2-MT and Caco-2-T cell than in Caco-2-H cells to stimulate cell proliferation. Altogether, our results provide evidence that one major mechanism whereby ras and PyMT oncogenes stimulate the proliferation of Caco-2 cells involves the up-regulation of an autocrine IGF-II/IGF1R loop as a result of increased IGF-II mRNA expression and IGF-II secretion.
Increased IGF-II mRNA expression in oncogenetransfected Caco-2 cells is selectively mediated by a PKC-dependent pathway At this point of the study we sought to gain insight into the cytoplasmic signalling molecules involved in the stimulation of IGF-II mRNA expression by oncogenic p21
ras and PyMT/pp60 c-src in Caco-2-MT and Caco-2-T cells. We ®rst examined the role of PKC since we previously demonstrated that, in these cells, conventional PKCa is overexpressed and that PKC is in a constitutively activated state (Delage et al., 1993) . We thus investigated whether PKC activation by PMA (162 nM, 4 h) or PKC inhibition by GoÈ 6976 (1 mM, 48 h), a potent conventional PKC inhibitor (MartinyBaron et al., 1993) , modi®ed IGF-II mRNA expression in all three Caco-2 cell lines ( Figure 4 ). Figure 4a shows that (i) PKC activation by PMA increased the level of the major 6.0 kb IGF-II transcript by about threefold in Caco-2-H cells but had no eect in oncogene-transfected cells in which PKC activity is constitutively increased ( Figure 4a) ; and (ii) PKC inhibition by GoÈ 6976 produced a signi®cant decrease (35 ± 50%) in the level of this transcript in all three cell lines ( Figure 4b ). Note that, under the conditions used, GoÈ 6976 did not aect cell viability, as assessed by the trypan blue exclusion test (data not shown).
To examine whether the stimulation of IGF-II mRNA expression by oncogenic p21 ras and PyMT/ pp60 c-src in Caco-2-MT and Caco-2-T cells was selectively mediated by PKC, we studied the implication in this process of MAP kinase and phosphatidylinositol 3-kinase (PI3-K), two cytoplasmic signalling molecules known as downstream targets for p21 ras and PyMT/pp60 c-src which participate into the control of gene transcription in various cell types (RodriguezViciana et al., 1994; Brown and Cooper, 1996; Marais and Marshall, 1996) . So, Caco-2-H, Caco-2-MT and Caco-2-T cells were treated for 48 h either with 100 mM PD98059, an inhibitor of MEK1 (Dudley et al., 1995) , the upstream activator of p42 and p44 MAP kinases in the Ras pathway, or with 100 mM LY294002, a speci®c PI3-K inhibitor (Vlahos et al., 1994) . Figure 5 shows that neither PD98059 (Figure 5a ) nor LY294002 ( Figure  5b ) did modify the IGF-II mRNA level in the three cell lines. These ®ndings argue for a role of PKC, but not of MAP kinase of PI3-K, in the control of IGF-II mRNA expression in control and oncogene-transfected Caco-2 cells and strongly suggest that, in the latter, there is a link between the increase in PKC expression and activity and the stimulation of IGF-II mRNA expression.
Increased IGF-II mRNA expression in oncogenetransfected Caco-2-MT and Caco-2-T cells involves a transcriptional mechanism
We next investigated the mechanism whereby oncogenic p21 ras and PyMT/pp60 c-src stimulated IGF-II Eect of the inhibition of MEK1 (PD98059) or PI3-K (LY294002) on IGF-II mRNA expression in control and oncogene-transfected Caco-2 cells. Total RNA (15 mg) prepared from Caco-2-H, Caco-2-MT and Caco-2-T cells treated for 48 h with or without 100 mM PD98059 (a) or 100 mM LY294002 (b) were subjected to Northern blot analysis using a 32 P-labelled IGF-II cDNA probe. The autoradiographs were quanti®ed by scanning densitometry and the amounts of the 6.0 kb IGF-II transcript were normalized with respect to the 28 S signal. The results are the means+s.e.m. from three experiments mRNA expression in Caco-2-MT and Caco-2-T cells. This mechanism could involve an increase in the stability of IGF-II mRNA and/or an increase in gene transcription. As a ®rst approach to address this issue, we compared the decline in the expression of the major 6.0 kb IGF-II transcript in Caco-2-H, Caco-2-MT and Caco-2-T cells after blockade of RNA synthesis by the potent inhibitor 5,6-dichlorobenzimidazole riboside (DRB) (Noda et al., 1988) . For these experiments, each of the three cell lines was treated for dierent time periods up to 12 h with 25 mg/ml of DRB before total RNA was extracted. Figure 6 shows that the decline in IGF-II mRNA in Caco-2-MT and Caco-2-T cells was almost identical with that observed in Caco-2-H cells, as assessed by the closely similar values of the half-life calculated for the 6.0 kb IGF-II transcript in the three cell lines (18, 19 and 17 h respectively). This ®nding indicates that the stimulation of IGF-II mRNA expression observed in oncogene-transfected Caco-2 cells does not result from stabilization of IGF-II mRNA and presumably involves a transcriptional mechanism.
PKC mediates oncogene stimulation of IGF-II gene P3 and P4 promoters in Caco-2-MT and Caco-2-T cells
To gain insight into the transcriptional mechanism involved in the stimulation of IGF-II mRNA expression by oncogenic p21 ras and PyMT/pp60
c-src
, we examined the activity of the P3 and P4 promoters of the IGF-II gene in control and oncogene-transfected Caco-2 cells. The three cell lines were transiently transfected with HUP3 or HUP4, two plasmids constructed by inserting fragments of the P3 (71229/ +140) or P4 (7546/+102) promoters of the human IGF-II gene upstream of the luciferase reporter gene (Holthuizen et al., 1993) . As shown in Figure 7a (Figure 7b) . These experiments showed that (i) PMA increased the activity of P3 and P4 promoters by 2.5-and 4-fold in Caco-2-H cells versus 1.2-and 1.4-fold in Caco-2-MT and Caco-2-T cells and (ii) that GoÈ 6976 signi®cantly reduced the activity of both promoters by 25 ± 35% in all three cell lines. Taken together, the above ®ndings indicate that PKC activates the IGF-II gene in Caco-2 cells and strongly argue for the increase in PKC expression and activity previously shown in Caco-2-MT and Caco-2-T cells (Delage et al., 1993) being responsible for the increase in IGF-II gene expression reported here.
PKC stimulates the activity of IGF-II gene P3 and P4 promoters through Sp1 activation
The P3 and P4 promoters of the human IGF-II gene contain several speci®c sites for the Sp1 transcription factor (Holthuizen et al., 1990) . Since previous studies suggested a role for PKC in the transcription of Sp1-regulated genes (Obeid et al., 1992; D'Angelo et al., 1996) , we wondered whether PKC activted the P3 and P4 promoters of the IGF-II gene through an action on Sp1. As a ®rst approach to address this issue, nuclear extracts were prepared from Caco-2-H, Caco-2-MT and Caco-2-T cells and analysed by EMSA for Sp1 DNA-binding activity, using a 32 P-labelled oligonucleotide containing the Sp1 consensus sequence. In all three cell lines, this activity appeared in the form of two DNA-protein complexes with the upper complex exhibiting a higher intensity than the lower ( Figure  8a ), which is in accordance with results reported for other cell types (Ye et al., 1996; Yurochko et al., 1997) . These complexes designated as complex 1 and complex 2 respectively were speci®c since their intensity was decreased in a concentration-dependent manner and/or was completely competed away by the unlabelled oligonucleotide containing the Sp1 motif (Figure 8a ). The use of antibodies speci®c for Sp1 and Sp3, another member of the Sp1 family which shares DNA-binding speci®city with Sp1 (Ye et al., 1996) , enabled us to determine that complex 1 is predominantly constituted of Sp1 and that Sp3 is the main component of complex 2 (Figure 8b ). More important, Figure 8a provides evidence for a marked increase in the intensity of complex 1 as compared to the intensity observed in Caco-2-H cells, indicating that in these cells Sp1 is stimulated as a result of the expression of oncogenic p21 ras or PyMT/pp60 c-src . To investigate whether PKC regulated Sp1 DNAbinding activity in colonic cells, nuclear extracts were prepared from Caco-2-H, Caco-2-MT and Caco-2-T cells after they had been treated for 24 h with or without 1 mM GoÈ 6976. EMSA analysis of these extracts showed that the treatment with GoÈ 6976 decreased Sp1 DNA-binding activity in all three cell lines, thus Oncogene stimulation of IGF-II expression through a PKC pathway A Cadoret et al suggesting a role for PKC in the control of Sp1 activity in human colonic cells (Figure 9a ). Moreover, this result implies that, in oncogene-transfected Caco-2 cells, overexpressed and activated PKC was responsible for increased Sp1 DNA-binding activity.
To approach the mechanism whereby PKC increased this activity in these cells, we next investigated the eect of PMA on Sp1 expression in control and oncogene-transfected Caco-2 cells. In these assays, total cell extracts prepared from Caco-2-H, Caco-2-MT and Caco-2-T cells which had been treated with or without PMA (162 nM, 4 h) were analysed by SDS ± PAGE and immunoblotted with an antibody speci®c for Sp1. As shown in Figure 9b , Sp1 was expressed as two bands, which is in accordance with results reported by others (D'Angelo et al., 1996) . Of interest, Sp1 expression was increased in Caco-2-MT and Caco-2-T cells as compared to Caco-2-H cells, suggesting that this increase was due to constitutively increased PKC activity in the oncogene-transfected cells. In support of this hypothesis, the activation of PKC by PMA in Caco-2-H cells stimulated Sp1 expression while it had no appreciable eect in Caco-2-MT and Caco-2-T cells. Taken together, our results indicate that the increase in the activity of P3 and P4 promoters of the IGF-II gene observed in oncogene-transfected Caco-2 cells is paralleled by an increase in Sp1 expression and DNA-binding activity which correlates with PKCa overexpression and PKC activation in these cell lines.
Discussion
We previously reported that Caco-2 cells transfected by ras or PyMT oncogenes exhibited increased proliferation together with PKCa overexpression and PKC activation (Delage et al., 1993; Baron-Delage et al., 1994) . In this study, we sought to examine whether the up-regulation of Caco-2 cell proliferation by ras and PyMT oncogenes involved the stimulation of the autrocrine IGF-II/IF1R loop described in these cells (Lahm et al., 1994; Zarrilli et al., 1994) and if so, to analyse the role of overexpressed and activated PKC. Although each of these oncogene-transfected Caco-2 cells expresses a speci®c oncoprotein, both behaved almost identically for all the parameters examined in our previous (Delage et al., 1993; Baron-Delage et al., 1994 Levy et al., 1996; Cadoret et al., 1997) and present studies. This may be explained by the ®nding that oncogenic PyMT/pp60 c-src produced a constitutive increase in the activity of endogenous p21 ras in Caco-2-MT cells which was closely similar to that due to the oncogenic activation of p21 ras in Caco-2-T cells (Baron- Delage et al., 1994) , arguing for the activation of the Ras signal transduction pathway in both cell lines.
In accordance with previous studies which examined the IGF system in parental Caco-2 cells (Hoe¯ich et al., 1994; Zhang et al., 1995) , we observed that control vector Caco-2-H cells expressed the IGF1R and IGF2R at the mRNA and/or protein levels, produced signi®cant amounts of IGF-II but not IGF-I, and secreted IGFBP-2 and IGFBP-4 in the culture medium. Also in agreement with what was reported for Caco-2 cells (Lahm et al., 1994; Zarrilli et al., 1994 Zarrilli et al., , 1996 , we provided evidence for an autocrine IGF-II/IGF1R loop functioning in Caco-2-H cells, as supported by the reproducible and signi®cant 28% decrease in the proliferation of these cells caused by anti-IGF-II and aIR3 antibodies. Finally, Caco-2-H cells, like Caco-2 cells (Zarrilli et al., 1994) , were found to fairly respond to exogenously added IGFs for stimulation of their proliferation.
In oncogene-transfected Caco-2-MT and Caco-2-T cells, the IGF1R and IGF2R levels were similar to those determined in control Caco-2-H cells, indicating no eect of oncogenic p21 ras and PyMT/pp60 c-src on the expression of these receptors. This ®nding can be compared with that of recent studies (Guo et al., 1992; Adenis et al., 1995; Zenilman and Graham, 1997) which found no signi®cant dierence in IGF1R expression between malignant and normal colorectal tissues. In contrast, Caco-2-MT and Caco-2-T cells exhibited a marked increase in IGF-II mRNA expression. This increase did not result from stabilization of IGF-II mRNA and traduced the activation of the IGF-II gene by oncogenic p21 ras and PyMT/ pp60 c-src , as supported by the unmodi®ed half-life of the major 6.0 kb IGF-II transcript along with the threefold increase in the activity of the P3 and P4 promoters of the IGF-II gene observed in oncogenetransfected Caco-2 cells relative to the controls. As a result of IGF-II gene activation, Caco-2-MT and Caco-2-T cells exhibited increased IGF-II secretion. The increased amount of IGF-II secreted into the culture medium by these cells was fully responsible for the oncogene-induced stimulation of their proliferation. Indeed, anti-IGF-II and aIR3 antibodies, which reduced the proliferation of Caco-2-MT and Caco-2-T cells by 54%, completely abolished the twofold constitutive increase in the number of these cells relative to the number of Caco-2-H cells. The ®nding that both antibodies were equally potent to normalize the proliferation of Caco-2-MT and Caco-2-T cells strongly argues for the eect of endogenous IGF-II on this process being mediated by IGF1Rs and rules out an action through insulin receptors as has been recently reported for exogenous IGF-II in 3T3 ®broblasts (Morrione et al., 1997) . In further support for this hypothesis, we found that, in both oncogene-transfected cell lines, IGF1Rs exhibited enhanced autophosphorylation whereas insulin receptors had decreased functional activity (Baron- Delage et al., 1994) . Unlike Caco-2-H cells, Caco-2-MT and Caco-2-T cells failed to respond to exogenously added IGFs. This could be explained by the increased tyrosine kinase activity of their IGF1Rs and also by the increased secretion of IGFBP-4, an IGFBP shown to inhibit IGF-I and IGF-II-mediated cell growth in the HT-29 human colon carcinoma cell line (Culouscou and Shoyab, 1991) . However, this latter possibility seems unlikely since addition of an antibody directed against IGFBP-4 into the incubation medium did not improve the mitogenic response of oncogene-transfected cells to exogenously added IGFs (data not shown). Considered together, the above results provide evidence that one major mechanism whereby oncogenic p21 ras and PyMT/ pp60 c-src stimulate the proliferation of Caco-2MT and Caco-2-T cells consists of the up-regulation, through IGF-II gene activation, of the autocrine IGF-II/IGF1R loop functioning in Caco-2 cells. These results suggest that IGF-II overexpression is capable of mediating the malignant progression of Caco-2 cells similar to what has been reported for MCF-7 breast tumor cells (Cullen et al., 1992) and oncogene-transfected pancreatic cells (Christofori et al., 1994) . Moreover, our study stresses the fact that IGF1Rs are important for the transformation of colonic cells even though their expression is unaltered in this cell type (Guo et al., 1992; Adenis et al., 1995; Zenilman and Graham, 1997 ; and the present study). It thus extends previous studies which provided evidence for a major role of this receptor in the transformation of other cell types by ras (Sell et al., 1994) , or SV40 T antigen (Sell et al., 1993) or bovine papilloma virus (Morrione et al., 1995) .
Increased IGF-II production has been reported for various human tumors (Toretsky and Helman, 1996) including colorectal cancer (Tricoli et al., 1986; Lamonerie et al., 1995) . However, none of the cited studies investigated a connection between increased IGF-II production and a speci®c signal transduction pathway in transformed cells. The models of ras-and PyMT-transfected Caco-2 cells used in this study enabled us to establish that, in human colonic cells, IGF-II gene expression is increased as a result of the oncogenic activation of the Ras pathway. Further, we show that the stimulation of IGF-II gene expression by oncogenic Ras is selectively mediated by PKC, a kinase exhibiting increased expression and activity in Caco-2-MT and Caco-2-T cells (Delage et al., 1993) . The speci®c role of PKC is supported by the ®nding that the PKC inhibitor GoÈ 6976, but not the MEK1 inhibitor PD98059 or the PI3-K inhibitor LY294002, reduced IGF-II mRNA expression in these cells as well as in controls. Accordingly, we show that the inhibition of PKC by GoÈ 6976 signi®cantly reduced the stimulation of the IGF-II gene P3 and P4 promoter activity in all three cell lines whereas the activation of PKC by PMA resulted in a signi®cant stimulation of both P3 and P4 promoter activity and IGF-II gene expression in control cells but not in oncogene-transfected cells. These ®ndings are consistent with a role of PKC in IGF-II gene activation in Caco-2 cells and suggest that overexpressed and activated PKC is responsible for increased IGF-II gene transcription and expression in oncogene-transfected Caco-2 cells. One of the mechanisms whereby PKC activated the IGF-II gene probably involved activation of the Sp1 transcription factor. In support of this hypothesis, we found that increased PKC expression and activity correlated with increased Sp1 expression and DNA-binding activity in oncogenetransfected Caco-2 cells. Furthermore, PKC inhibition by GoÈ 6976 reduced the activity of this transcription factor in the three Caco-2 cell lines whereas PKC activation by PMA stimulated Sp1 expression in control but not in oncogene-transfected cells in which PKC activity is constitutively increased. These ®ndings support the notion that PKC may increase IGF-II gene transcription from the P3 and P4 promoters through Sp1 activation. A role for Sp1 was already reported in the stimulation of the activity of the human IGF-II gene P4 promoter by the retinoblastoma gene product (Kim et al., 1992) . Moreover, several genes were shown to be activated by PKC through Sp1 activation including the genes encoding PKCb (Obeid et al., 1992) , the Waf1/cip1 protein (Biggs et al., 1996) and the platelet thromboxane receptor (D'Angelo et al., 1996) . The question of whether this is actually the case for the IGF-II gene in Caco-2 cells requires further studies to be conclusively answered.
In conclusion, our study shows that one major mechanism whereby oncogenic p21 ras and PyMT/ pp60 c-src deregulate the proliferation of human colonic cells involves stimulation of IGF-II gene transcription and increased autocrine IGF-II production through a PKC-mediated pathway which may involve Sp1 activation. These data which provide the ®rst evidence for a role of PKC in the regulation of the IGF-II gene shed new light on the mechanisms underlying the malignant transformation of human colonic cells expressing oncogenic p21 ras or pp60 c-src , two of the most frequently observed alterations in colorectal cancer. [a- 32 P]dCTP (3000 Ci/mmol), Hybond N + membranes, hyper®lms-MP and ECL detection system were obtained from Amersham Corp. The mouse monoclonal antibody against human IGF1R (aIR3) was purchased from Oncogene Science. Human recombinant IGF-II and GoÈ 6976 were from Calbiochem. Mouse monoclonal antihuman IGF-II, rabbit polyclonal anti-IGFBP-4 and mouse monoclonal anti-phosphotyrosine (PY20) antibodies were from Upstate Biotechnology Inc. Mouse monoclonal antiSp1 and rabbit polyclonal anti-SP3 antibodies were obtained from Santa Cruz Biotechnology. Sp1 oligonucleotide was purchased from Promega. PD98059 was obtained from Biolabs. Dulbecco's modi®ed Eagle's medium (DMEM) was from Eurobio and FCS from ATGC. Other reagents were purchased from Sigma.
Materials and methods

Reagents
Cell lines
The transfected Caco-2 cells lines used in this study have been previously described Delage et al., 1993 . These include Caco-2 cells transfected with Homer 6, a plasmid vector containing a MoMSVLTRdriven G418 resistance gene (Caco-2-H cells) which was recombined either with the cDNA encoding the PyMT antigen (Caco-2-MT cells) or with a mutated (Val-12) human Ha-ras gene (Caco-2-T cells). The oncogenetransfected Caco-2 cells are regularly veri®ed for overexpression of PKCa mRNA transcripts (Delage et al., 1993) , which is taken as an index of maintenance of functional oncogenes in these cell lines. Cells were routinely grown in 100 mm-dishes in a humidi®ed incubator equilibrated with 5% CO 2 at 378C, using DMEM (4.5 g/liter glucose) supplemented with 15% FCS, 2 mM glutamine, 100 units/ml of penicillin and 100 mg/ml of streptomycin.
Measurement of secreted IGFs and IGFBPs in conditioned medium
Conditioned media (CM) were prepared for measurement of secreted IGFs and IGFBPs as previously described Hossenlopp et al., 1986) . Cells were seeded into 100 mm-dishes and cultured in 15% FCS medium for 4 days. Then, cells were washed twice with SFM and maintained in this medium for 48 h. CM were collected and stored at 7208C until further use. Before assaying CM for IGFs, the IGFBPs were eliminated by ®ltration on a Ultrogel AcA 54 column. The eluates were lyophilized and desalted on Sephadex G25 columns. Then, the amounts of IGFs were measured by radioimmunoassay, as previously described .
Ligand blot analysis of CM was performed as previously described (Hossenlopp et al., 1986) . Brie¯y, CM were desalted on Sephadex G25 columns, lyophilized and submitted to SDS ± PAGE (12.5% (w/v) acrylamide) under non-reducing conditions followed by electrotransfer onto nitrocellulose. The dierent IGFBPs species were detected by incubation with a mixture of 125 I-IGF-I and 125 I-IGF-II followed by autoradiography.
Northern hybridization
Total RNA was isolated by the method of Chirgwin et al. (1979) and analysed by Northern blot as previously described (Cadoret et al., 1997) . Brie¯y, total RNA (15 mg) was electrophoresed through 0.8% agarose-6% formaldehyde gels and blotted onto Hybond-N + nylon membranes. The RNA blots were hybridized to 32 P-labelled cDNA probes speci®c for IGF-I, IGF-II, IGF1R or IGF2R. After hybridization, blots were washed to high stringency and autoradiographed. RNA was quanti®ed and normalized by dierential densitometric scanning of the speci®c bands versus the 28 S bands. Where indicated, cells were treated for the indicated time periods with either 25 mg/ml of the RNA synthesis inhibitor DRB (Noda et al., 1988) or with 162 nM PMA or 1 mM GoÈ 6976 or 100 mM PD98059 or 100 mM LY294002 before total RNA was extracted, as described above.
Flow cytometry analysis
After trypsinization, cells were washed once in ice-cold phosphate-buered saline (PBS) and then incubated with aIR3 (0.5 mg/ml) or control isotypic antibody for 30 min at 48C. Cells were washed twice with PBS and were subsequently incubated for 30 min with a¯uorescein isothiocyanate (FITC)-conjugated goat anti-mouse antibody. After two ®nal washes with PBS, cells were resuspended in PBS at a concentration of 10 6 cells/ml and were subjected to cyto¯uorimetry analysis using a cyto¯uorograph IIs (Ortho Diagnostic System).
Proliferation assays
Twenty-four hours after plating the cells (5610 4 cells/well), the medium was discarded and the culture was continued in SFM. After 48 h, cells were incubated in SFM in the presence or absence of the following: 15% FCS, 10 78 M IGF-I or IGF-II, 10 mg/ml of aIR3, 5 mg/ml of a monoclonal anti-human IGF-II antibody or 10 mg/ml of control isotypic IgG. One day later, cell number was estimated using a colorimetric assay in which mitochondrial dehydrogenase reduction of a tetrazolium salt (MTT) is detected. The absorbance of each well was then measured at 540 nm and cell number was determined from comparison with a standard curve established in preliminary assays.
Western blotting
Transfected Caco-2 cells were scraped o into lysis buer (20 mM HEPES pH 8, 0.1% SDS, 1% Triton X100, 0.5% sodium deoxycholate, 5 mM EDTA, 5 mM EGTA, 50 mM NaCl, supplemented with protease and phosphatase inhibitors). After centrifugation of the lysate for 10 min at 13 000 g to remove nuclei, the supernatant was stored at 7808C. For detection of IGF1R phosphorylation, equal amounts of protein (300 mg) were immunoprecipitated with aIR3 overnight at 48C. Immunocomplexes were collected on protein G-agarose beads, washed four times in lysis buer and subjected to SDS±PAGE (7.5% (w/v) acrylamide) followed by electrotransfer onto nitrocellulose membranes. Phosphorylated proteins were detected by immunoblotting with the PY20 anti-phosphotyrosine antibody. For detection of Sp1, total cell extracts (40 mg) prepared from Caco-2 cells which had been treated with or without PMA (162 nM), 4 h) were subjected to SDS ± PAGE (7.5% (w/v) acrylamide) and electrotransferred onto nitrocellulose membranes. Blots were then incubated with a monoclonal antibody speci®c for Sp1. The signals were visualized with the ECL detection system.
Transient transfection and luciferase assays
The assays were performed as recently described (Cadoret et al., 1997) . Cells were transfected by the calcium phosphate precipitation method with 5 mg of HUP3 or HUP4 or the control vector (generous gift from Dr E Holthuizen, Utrecht University, Netherland). The HUP3 and HUP4 reporter plasmids contain fragments of either the P3 (71229/+140) or the P4 (7546/+102) promoters of the human IGF-II gene upstream of the luciferase reporter gene (Holthuizen et al., 1993) . After transfection, cells were incubated for 24 h in medium containing 0.3% FCS and then in the presence or absence of 162 nM PMA or 1 mM GoÈ 6976 for 4 h or 24 h respectively. Luciferase activity was assayed in lysis buer containing 50 mM ATP and 100 mM luciferin, using a monolight 2010 luminometer (Berthold), as previously described (Cadoret et al., 1997) . All results are given as the normalized luciferase activity (dierence between the P3-or P4-mediated luciferase activity and the luciferase activity devoted to the control vector, normalized to the protein concentration).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts prepared from control and transfected Caco-2 cells, which had been treated for 24 h with or without 1 mM GoÈ 6976, were analysed by EMSA as previously described (Cadoret et al., 1997) . DNA-binding reactions were carried out in a binding reaction mixture containing a 32 P-labelled double-stranded Sp1 (30 000 ± 40 000 c.p.m.) probe, in the presence or absence of increasing concentrations of the unlabelled Sp1 oligonucleotide. For antibody supershift assay, nuclear extracts were incubated overnight at 48C with speci®c Sp1 and Sp3 antibodies before the binding reaction was initiated).
Statistical analysis
Results are given as the means+s.e.m. for the indicated numbers of independently performed experiments. Differences between the mean values were evaluated by Student's t test.
